GLO1 and cancer: On the other hand, studies aimed at searching GLYI inhibitors may be equally worthwhile as a prospective treatment for cancer, since these inhibitors may induce severe dicarbonyl stress, allowing increased levels of AGEs to act as pro-apoptotic agents in cancer cells, particularly those showing high GLYI expressing-related multidrug-resistance [12,40].